nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—type 2 diabetes mellitus	0.199	0.602	CbGaD
Rimonabant—CYP3A4—type 2 diabetes mellitus	0.132	0.398	CbGaD
Rimonabant—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0271	0.06	CbGbCtD
Rimonabant—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0248	0.0548	CbGbCtD
Rimonabant—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.023	0.051	CbGbCtD
Rimonabant—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.02	0.0444	CbGbCtD
Rimonabant—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0196	0.0434	CbGbCtD
Rimonabant—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0196	0.0434	CbGbCtD
Rimonabant—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0181	0.04	CbGbCtD
Rimonabant—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0179	0.0396	CbGbCtD
Rimonabant—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0177	0.0391	CbGbCtD
Rimonabant—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0174	0.0386	CbGbCtD
Rimonabant—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0165	0.0366	CbGbCtD
Rimonabant—CYP2C9—Valsartan—type 2 diabetes mellitus	0.016	0.0353	CbGbCtD
Rimonabant—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0158	0.035	CbGbCtD
Rimonabant—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0157	0.0349	CbGbCtD
Rimonabant—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0149	0.0331	CbGbCtD
Rimonabant—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0148	0.0329	CbGbCtD
Rimonabant—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0144	0.0319	CbGbCtD
Rimonabant—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0142	0.0315	CbGbCtD
Rimonabant—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0136	0.03	CbGbCtD
Rimonabant—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.013	0.0288	CbGbCtD
Rimonabant—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0126	0.0279	CbGbCtD
Rimonabant—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0114	0.0252	CbGbCtD
Rimonabant—CYP1A2—Losartan—type 2 diabetes mellitus	0.0102	0.0225	CbGbCtD
Rimonabant—CYP2C9—Glyburide—type 2 diabetes mellitus	0.01	0.0222	CbGbCtD
Rimonabant—CYP2C9—Losartan—type 2 diabetes mellitus	0.00916	0.0203	CbGbCtD
Rimonabant—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00862	0.0191	CbGbCtD
Rimonabant—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00827	0.0183	CbGbCtD
Rimonabant—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00827	0.0183	CbGbCtD
Rimonabant—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00782	0.0173	CbGbCtD
Rimonabant—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00583	0.0129	CbGbCtD
Rimonabant—CYP3A4—Losartan—type 2 diabetes mellitus	0.00533	0.0118	CbGbCtD
Rimonabant—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000191	0.00136	CcSEcCtD
Rimonabant—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00135	CcSEcCtD
Rimonabant—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000189	0.00135	CcSEcCtD
Rimonabant—Anorexia—Glyburide—type 2 diabetes mellitus	0.000189	0.00135	CcSEcCtD
Rimonabant—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000189	0.00135	CcSEcCtD
Rimonabant—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000189	0.00135	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00134	CcSEcCtD
Rimonabant—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00134	CcSEcCtD
Rimonabant—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000186	0.00133	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000186	0.00133	CcSEcCtD
Rimonabant—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000186	0.00133	CcSEcCtD
Rimonabant—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000186	0.00132	CcSEcCtD
Rimonabant—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000186	0.00132	CcSEcCtD
Rimonabant—Nausea—Repaglinide—type 2 diabetes mellitus	0.000185	0.00132	CcSEcCtD
Rimonabant—Asthenia—Glipizide—type 2 diabetes mellitus	0.000185	0.00132	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000185	0.00132	CcSEcCtD
Rimonabant—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000185	0.00132	CcSEcCtD
Rimonabant—Malnutrition—Metformin—type 2 diabetes mellitus	0.000183	0.0013	CcSEcCtD
Rimonabant—Pruritus—Glipizide—type 2 diabetes mellitus	0.000183	0.0013	CcSEcCtD
Rimonabant—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000182	0.0013	CcSEcCtD
Rimonabant—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00018	0.00128	CcSEcCtD
Rimonabant—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000179	0.00127	CcSEcCtD
Rimonabant—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000178	0.00127	CcSEcCtD
Rimonabant—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00127	CcSEcCtD
Rimonabant—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000178	0.00127	CcSEcCtD
Rimonabant—Infection—Gliclazide—type 2 diabetes mellitus	0.000177	0.00126	CcSEcCtD
Rimonabant—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000177	0.00126	CcSEcCtD
Rimonabant—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000176	0.00125	CcSEcCtD
Rimonabant—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000175	0.00125	CcSEcCtD
Rimonabant—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000175	0.00125	CcSEcCtD
Rimonabant—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000173	0.00124	CcSEcCtD
Rimonabant—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000173	0.00123	CcSEcCtD
Rimonabant—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000173	0.00123	CcSEcCtD
Rimonabant—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000173	0.00123	CcSEcCtD
Rimonabant—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000173	0.00123	CcSEcCtD
Rimonabant—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000172	0.00123	CcSEcCtD
Rimonabant—Convulsion—Orlistat—type 2 diabetes mellitus	0.000172	0.00123	CcSEcCtD
Rimonabant—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00123	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000172	0.00122	CcSEcCtD
Rimonabant—Tremor—Metformin—type 2 diabetes mellitus	0.000171	0.00122	CcSEcCtD
Rimonabant—Dizziness—Glipizide—type 2 diabetes mellitus	0.000171	0.00122	CcSEcCtD
Rimonabant—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000171	0.00122	CcSEcCtD
Rimonabant—Anxiety—Valsartan—type 2 diabetes mellitus	0.00017	0.00122	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00017	0.00121	CcSEcCtD
Rimonabant—Tension—Irbesartan—type 2 diabetes mellitus	0.000169	0.00121	CcSEcCtD
Rimonabant—Angiopathy—Losartan—type 2 diabetes mellitus	0.000169	0.00121	CcSEcCtD
Rimonabant—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000169	0.00121	CcSEcCtD
Rimonabant—Anxiety—Orlistat—type 2 diabetes mellitus	0.000168	0.0012	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000168	0.0012	CcSEcCtD
Rimonabant—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000168	0.0012	CcSEcCtD
Rimonabant—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000167	0.00119	CcSEcCtD
Rimonabant—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000167	0.00119	CcSEcCtD
Rimonabant—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000166	0.00118	CcSEcCtD
Rimonabant—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000165	0.00118	CcSEcCtD
Rimonabant—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000165	0.00118	CcSEcCtD
Rimonabant—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00117	CcSEcCtD
Rimonabant—Vomiting—Glipizide—type 2 diabetes mellitus	0.000164	0.00117	CcSEcCtD
Rimonabant—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000164	0.00117	CcSEcCtD
Rimonabant—Infection—Valsartan—type 2 diabetes mellitus	0.000163	0.00116	CcSEcCtD
Rimonabant—Rash—Glipizide—type 2 diabetes mellitus	0.000163	0.00116	CcSEcCtD
Rimonabant—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000163	0.00116	CcSEcCtD
Rimonabant—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000163	0.00116	CcSEcCtD
Rimonabant—Headache—Glipizide—type 2 diabetes mellitus	0.000162	0.00115	CcSEcCtD
Rimonabant—Tremor—Irbesartan—type 2 diabetes mellitus	0.000162	0.00115	CcSEcCtD
Rimonabant—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000161	0.00115	CcSEcCtD
Rimonabant—Infection—Orlistat—type 2 diabetes mellitus	0.000161	0.00115	CcSEcCtD
Rimonabant—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000161	0.00115	CcSEcCtD
Rimonabant—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00016	0.00114	CcSEcCtD
Rimonabant—Tension—Losartan—type 2 diabetes mellitus	0.000159	0.00114	CcSEcCtD
Rimonabant—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000159	0.00114	CcSEcCtD
Rimonabant—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000159	0.00114	CcSEcCtD
Rimonabant—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000159	0.00113	CcSEcCtD
Rimonabant—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000159	0.00113	CcSEcCtD
Rimonabant—Nervousness—Losartan—type 2 diabetes mellitus	0.000158	0.00113	CcSEcCtD
Rimonabant—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000157	0.00112	CcSEcCtD
Rimonabant—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.00112	CcSEcCtD
Rimonabant—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000157	0.00112	CcSEcCtD
Rimonabant—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000157	0.00112	CcSEcCtD
Rimonabant—Anorexia—Valsartan—type 2 diabetes mellitus	0.000156	0.00111	CcSEcCtD
Rimonabant—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000156	0.00111	CcSEcCtD
Rimonabant—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00111	CcSEcCtD
Rimonabant—Headache—Pioglitazone—type 2 diabetes mellitus	0.000155	0.00111	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000155	0.0011	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000154	0.0011	CcSEcCtD
Rimonabant—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000154	0.0011	CcSEcCtD
Rimonabant—Nausea—Glipizide—type 2 diabetes mellitus	0.000153	0.00109	CcSEcCtD
Rimonabant—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000153	0.00109	CcSEcCtD
Rimonabant—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00109	CcSEcCtD
Rimonabant—Tremor—Losartan—type 2 diabetes mellitus	0.000152	0.00109	CcSEcCtD
Rimonabant—Rash—Glimepiride—type 2 diabetes mellitus	0.000152	0.00108	CcSEcCtD
Rimonabant—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000152	0.00108	CcSEcCtD
Rimonabant—Rash—Sitagliptin—type 2 diabetes mellitus	0.000151	0.00108	CcSEcCtD
Rimonabant—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000151	0.00108	CcSEcCtD
Rimonabant—Headache—Glimepiride—type 2 diabetes mellitus	0.000151	0.00108	CcSEcCtD
Rimonabant—Headache—Sitagliptin—type 2 diabetes mellitus	0.00015	0.00107	CcSEcCtD
Rimonabant—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00106	CcSEcCtD
Rimonabant—Infection—Metformin—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Rimonabant—Insomnia—Valsartan—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Rimonabant—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000147	0.00105	CcSEcCtD
Rimonabant—Insomnia—Orlistat—type 2 diabetes mellitus	0.000147	0.00104	CcSEcCtD
Rimonabant—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Rimonabant—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Rimonabant—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Rimonabant—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000145	0.00104	CcSEcCtD
Rimonabant—Skin disorder—Metformin—type 2 diabetes mellitus	0.000145	0.00103	CcSEcCtD
Rimonabant—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Rimonabant—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Rimonabant—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Rimonabant—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Rimonabant—Nausea—Glimepiride—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Rimonabant—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Rimonabant—Asthenia—Glyburide—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Rimonabant—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Rimonabant—Anorexia—Metformin—type 2 diabetes mellitus	0.000142	0.00101	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000142	0.00101	CcSEcCtD
Rimonabant—Fatigue—Valsartan—type 2 diabetes mellitus	0.000141	0.00101	CcSEcCtD
Rimonabant—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000141	0.00101	CcSEcCtD
Rimonabant—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000141	0.001	CcSEcCtD
Rimonabant—Pruritus—Glyburide—type 2 diabetes mellitus	0.000141	0.001	CcSEcCtD
Rimonabant—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00014	0.001	CcSEcCtD
Rimonabant—Infection—Irbesartan—type 2 diabetes mellitus	0.00014	0.000998	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00014	0.000997	CcSEcCtD
Rimonabant—Fatigue—Orlistat—type 2 diabetes mellitus	0.00014	0.000996	CcSEcCtD
Rimonabant—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000139	0.000993	CcSEcCtD
Rimonabant—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000986	CcSEcCtD
Rimonabant—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000138	0.000985	CcSEcCtD
Rimonabant—Anxiety—Losartan—type 2 diabetes mellitus	0.000138	0.000983	CcSEcCtD
Rimonabant—Rash—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000978	CcSEcCtD
Rimonabant—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000977	CcSEcCtD
Rimonabant—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000137	0.000976	CcSEcCtD
Rimonabant—Tension—Ramipril—type 2 diabetes mellitus	0.000137	0.000975	CcSEcCtD
Rimonabant—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000136	0.000971	CcSEcCtD
Rimonabant—Headache—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000971	CcSEcCtD
Rimonabant—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000136	0.00097	CcSEcCtD
Rimonabant—Nervousness—Ramipril—type 2 diabetes mellitus	0.000135	0.000965	CcSEcCtD
Rimonabant—Dry mouth—Losartan—type 2 diabetes mellitus	0.000135	0.000965	CcSEcCtD
Rimonabant—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000134	0.000958	CcSEcCtD
Rimonabant—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000134	0.000956	CcSEcCtD
Rimonabant—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000134	0.000956	CcSEcCtD
Rimonabant—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000134	0.000955	CcSEcCtD
Rimonabant—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000132	0.000945	CcSEcCtD
Rimonabant—Infection—Losartan—type 2 diabetes mellitus	0.000132	0.000939	CcSEcCtD
Rimonabant—Tremor—Ramipril—type 2 diabetes mellitus	0.000131	0.000931	CcSEcCtD
Rimonabant—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00013	0.000927	CcSEcCtD
Rimonabant—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00013	0.000926	CcSEcCtD
Rimonabant—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00013	0.000924	CcSEcCtD
Rimonabant—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000921	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000129	0.000919	CcSEcCtD
Rimonabant—Fatigue—Metformin—type 2 diabetes mellitus	0.000129	0.000918	CcSEcCtD
Rimonabant—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000128	0.000914	CcSEcCtD
Rimonabant—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000128	0.000913	CcSEcCtD
Rimonabant—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000128	0.000913	CcSEcCtD
Rimonabant—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000902	CcSEcCtD
Rimonabant—Anorexia—Losartan—type 2 diabetes mellitus	0.000126	0.000901	CcSEcCtD
Rimonabant—Vomiting—Glyburide—type 2 diabetes mellitus	0.000126	0.000901	CcSEcCtD
Rimonabant—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000126	0.0009	CcSEcCtD
Rimonabant—Rash—Glyburide—type 2 diabetes mellitus	0.000125	0.000894	CcSEcCtD
Rimonabant—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000125	0.000893	CcSEcCtD
Rimonabant—Headache—Glyburide—type 2 diabetes mellitus	0.000125	0.000888	CcSEcCtD
Rimonabant—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000122	0.000873	CcSEcCtD
Rimonabant—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000122	0.000871	CcSEcCtD
Rimonabant—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000122	0.000871	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.000867	CcSEcCtD
Rimonabant—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000121	0.000866	CcSEcCtD
Rimonabant—Convulsion—Ramipril—type 2 diabetes mellitus	0.000121	0.000861	CcSEcCtD
Rimonabant—Insomnia—Losartan—type 2 diabetes mellitus	0.00012	0.000855	CcSEcCtD
Rimonabant—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000119	0.000849	CcSEcCtD
Rimonabant—Anxiety—Ramipril—type 2 diabetes mellitus	0.000118	0.000843	CcSEcCtD
Rimonabant—Nausea—Glyburide—type 2 diabetes mellitus	0.000118	0.000842	CcSEcCtD
Rimonabant—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000118	0.000842	CcSEcCtD
Rimonabant—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000118	0.000842	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000118	0.00084	CcSEcCtD
Rimonabant—Asthenia—Valsartan—type 2 diabetes mellitus	0.000118	0.000839	CcSEcCtD
Rimonabant—Asthenia—Orlistat—type 2 diabetes mellitus	0.000116	0.000829	CcSEcCtD
Rimonabant—Pruritus—Valsartan—type 2 diabetes mellitus	0.000116	0.000827	CcSEcCtD
Rimonabant—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000116	0.000827	CcSEcCtD
Rimonabant—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000115	0.000822	CcSEcCtD
Rimonabant—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000115	0.000822	CcSEcCtD
Rimonabant—Pruritus—Orlistat—type 2 diabetes mellitus	0.000115	0.000817	CcSEcCtD
Rimonabant—Fatigue—Losartan—type 2 diabetes mellitus	0.000114	0.000815	CcSEcCtD
Rimonabant—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000113	0.000809	CcSEcCtD
Rimonabant—Rash—Gliclazide—type 2 diabetes mellitus	0.000113	0.000802	CcSEcCtD
Rimonabant—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000112	0.000802	CcSEcCtD
Rimonabant—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000112	0.0008	CcSEcCtD
Rimonabant—Headache—Gliclazide—type 2 diabetes mellitus	0.000112	0.000797	CcSEcCtD
Rimonabant—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000795	CcSEcCtD
Rimonabant—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000111	0.000794	CcSEcCtD
Rimonabant—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000111	0.00079	CcSEcCtD
Rimonabant—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000788	CcSEcCtD
Rimonabant—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00011	0.000784	CcSEcCtD
Rimonabant—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000108	0.000773	CcSEcCtD
Rimonabant—Dizziness—Valsartan—type 2 diabetes mellitus	0.000108	0.000773	CcSEcCtD
Rimonabant—Anorexia—Ramipril—type 2 diabetes mellitus	0.000108	0.000773	CcSEcCtD
Rimonabant—Dizziness—Orlistat—type 2 diabetes mellitus	0.000107	0.000764	CcSEcCtD
Rimonabant—Asthenia—Metformin—type 2 diabetes mellitus	0.000107	0.000764	CcSEcCtD
Rimonabant—Nausea—Gliclazide—type 2 diabetes mellitus	0.000106	0.000756	CcSEcCtD
Rimonabant—Pruritus—Metformin—type 2 diabetes mellitus	0.000106	0.000753	CcSEcCtD
Rimonabant—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000105	0.000748	CcSEcCtD
Rimonabant—Vomiting—Valsartan—type 2 diabetes mellitus	0.000104	0.000743	CcSEcCtD
Rimonabant—Rash—Valsartan—type 2 diabetes mellitus	0.000103	0.000737	CcSEcCtD
Rimonabant—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000103	0.000737	CcSEcCtD
Rimonabant—Vomiting—Orlistat—type 2 diabetes mellitus	0.000103	0.000735	CcSEcCtD
Rimonabant—Insomnia—Ramipril—type 2 diabetes mellitus	0.000103	0.000733	CcSEcCtD
Rimonabant—Headache—Valsartan—type 2 diabetes mellitus	0.000103	0.000732	CcSEcCtD
Rimonabant—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000102	0.000729	CcSEcCtD
Rimonabant—Rash—Orlistat—type 2 diabetes mellitus	0.000102	0.000728	CcSEcCtD
Rimonabant—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000102	0.000728	CcSEcCtD
Rimonabant—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000102	0.000728	CcSEcCtD
Rimonabant—Headache—Orlistat—type 2 diabetes mellitus	0.000101	0.000724	CcSEcCtD
Rimonabant—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000721	CcSEcCtD
Rimonabant—Pruritus—Irbesartan—type 2 diabetes mellitus	9.97e-05	0.000711	CcSEcCtD
Rimonabant—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.88e-05	0.000705	CcSEcCtD
Rimonabant—Dizziness—Metformin—type 2 diabetes mellitus	9.87e-05	0.000704	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.82e-05	0.0007	CcSEcCtD
Rimonabant—Fatigue—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000699	CcSEcCtD
Rimonabant—Nausea—Valsartan—type 2 diabetes mellitus	9.74e-05	0.000694	CcSEcCtD
Rimonabant—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000687	CcSEcCtD
Rimonabant—Nausea—Orlistat—type 2 diabetes mellitus	9.62e-05	0.000686	CcSEcCtD
Rimonabant—Asthenia—Losartan—type 2 diabetes mellitus	9.51e-05	0.000678	CcSEcCtD
Rimonabant—Vomiting—Metformin—type 2 diabetes mellitus	9.49e-05	0.000677	CcSEcCtD
Rimonabant—Rash—Metformin—type 2 diabetes mellitus	9.41e-05	0.000671	CcSEcCtD
Rimonabant—Dermatitis—Metformin—type 2 diabetes mellitus	9.41e-05	0.000671	CcSEcCtD
Rimonabant—Pruritus—Losartan—type 2 diabetes mellitus	9.38e-05	0.000669	CcSEcCtD
Rimonabant—Headache—Metformin—type 2 diabetes mellitus	9.35e-05	0.000667	CcSEcCtD
Rimonabant—Dizziness—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000664	CcSEcCtD
Rimonabant—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000663	CcSEcCtD
Rimonabant—Diarrhoea—Losartan—type 2 diabetes mellitus	9.07e-05	0.000647	CcSEcCtD
Rimonabant—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000641	CcSEcCtD
Rimonabant—Vomiting—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.000639	CcSEcCtD
Rimonabant—Rash—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000634	CcSEcCtD
Rimonabant—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000633	CcSEcCtD
Rimonabant—Nausea—Metformin—type 2 diabetes mellitus	8.87e-05	0.000632	CcSEcCtD
Rimonabant—Headache—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000629	CcSEcCtD
Rimonabant—Dizziness—Losartan—type 2 diabetes mellitus	8.77e-05	0.000625	CcSEcCtD
Rimonabant—Vomiting—Losartan—type 2 diabetes mellitus	8.43e-05	0.000601	CcSEcCtD
Rimonabant—Nausea—Irbesartan—type 2 diabetes mellitus	8.37e-05	0.000597	CcSEcCtD
Rimonabant—Rash—Losartan—type 2 diabetes mellitus	8.36e-05	0.000596	CcSEcCtD
Rimonabant—Dermatitis—Losartan—type 2 diabetes mellitus	8.35e-05	0.000596	CcSEcCtD
Rimonabant—Headache—Losartan—type 2 diabetes mellitus	8.31e-05	0.000592	CcSEcCtD
Rimonabant—Asthenia—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000582	CcSEcCtD
Rimonabant—Pruritus—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000574	CcSEcCtD
Rimonabant—Nausea—Losartan—type 2 diabetes mellitus	7.88e-05	0.000562	CcSEcCtD
Rimonabant—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000555	CcSEcCtD
Rimonabant—Dizziness—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000536	CcSEcCtD
Rimonabant—Vomiting—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000516	CcSEcCtD
Rimonabant—Rash—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000511	CcSEcCtD
Rimonabant—Dermatitis—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000511	CcSEcCtD
Rimonabant—Headache—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000508	CcSEcCtD
Rimonabant—Nausea—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000482	CcSEcCtD
Rimonabant—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	8.51e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	8.51e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.48e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.48e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.48e-06	0.000109	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.44e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	8.43e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	8.43e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	8.43e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	8.43e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.36e-06	0.000107	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.22e-06	0.000105	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	8.16e-06	0.000105	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.11e-06	0.000104	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	8.09e-06	0.000104	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.97e-06	0.000102	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.89e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.89e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.85e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.84e-06	0.000101	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.78e-06	9.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.7e-06	9.86e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.69e-06	9.86e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.65e-06	9.81e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.61e-06	9.75e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	7.58e-06	9.72e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	7.52e-06	9.63e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.46e-06	9.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.45e-06	9.55e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.34e-06	9.41e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.34e-06	9.41e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.34e-06	9.41e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.21e-06	9.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.21e-06	9.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.21e-06	9.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.21e-06	9.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.08e-06	9.07e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.04e-06	9.02e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.04e-06	9.02e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.02e-06	8.99e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.93e-06	8.89e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.93e-06	8.89e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.93e-06	8.88e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.91e-06	8.86e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.87e-06	8.81e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.87e-06	8.81e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.8e-06	8.72e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.77e-06	8.68e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.77e-06	8.68e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.76e-06	8.66e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.76e-06	8.66e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.76e-06	8.66e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.74e-06	8.64e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.72e-06	8.61e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.71e-06	8.6e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.7e-06	8.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.7e-06	8.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.7e-06	8.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.7e-06	8.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.66e-06	8.53e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.65e-06	8.53e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.62e-06	8.49e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.6e-06	8.45e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.58e-06	8.43e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.54e-06	8.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.54e-06	8.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.54e-06	8.38e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.54e-06	8.38e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.52e-06	8.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.5e-06	8.33e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.46e-06	8.29e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.42e-06	8.23e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.15e-06	7.88e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.11e-06	7.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.06e-06	7.77e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.06e-06	7.77e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.06e-06	7.77e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.03e-06	7.73e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.01e-06	7.7e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.01e-06	7.7e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.01e-06	7.7e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6e-06	7.69e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.95e-06	7.63e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.9e-06	7.56e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.9e-06	7.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.87e-06	7.53e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.87e-06	7.53e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.85e-06	7.49e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.77e-06	7.4e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.76e-06	7.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.76e-06	7.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.76e-06	7.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.73e-06	7.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.73e-06	7.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.73e-06	7.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.73e-06	7.34e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.72e-06	7.33e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.69e-06	7.29e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.59e-06	7.16e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.56e-06	7.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.56e-06	7.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.56e-06	7.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.56e-06	7.13e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.54e-06	7.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.52e-06	7.08e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.5e-06	7.04e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.48e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.48e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.43e-06	6.97e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.43e-06	6.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.35e-06	6.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.33e-06	6.83e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.3e-06	6.79e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.27e-06	6.76e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.26e-06	6.74e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.26e-06	6.74e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.21e-06	6.68e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.21e-06	6.68e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.15e-06	6.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.14e-06	6.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.14e-06	6.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.14e-06	6.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.04e-06	6.46e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5e-06	6.4e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.96e-06	6.35e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.93e-06	6.31e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.89e-06	6.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.7e-06	6.02e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.64e-06	5.95e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.63e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.53e-06	5.81e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.53e-06	5.81e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.53e-06	5.81e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.53e-06	5.81e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.53e-06	5.8e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.51e-06	5.78e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.51e-06	5.78e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.49e-06	5.76e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.49e-06	5.76e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.47e-06	5.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.45e-06	5.71e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.45e-06	5.71e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.45e-06	5.7e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.45e-06	5.7e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.42e-06	5.66e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.42e-06	5.66e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.42e-06	5.66e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.41e-06	5.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.39e-06	5.63e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.32e-06	5.54e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.31e-06	5.53e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.28e-06	5.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.26e-06	5.46e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.2e-06	5.39e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.17e-06	5.34e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.12e-06	5.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.09e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.04e-06	5.18e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.02e-06	5.16e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4e-06	5.13e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.99e-06	5.11e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.96e-06	5.08e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.96e-06	5.08e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.96e-06	5.08e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.92e-06	5.02e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.89e-06	4.99e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.88e-06	4.98e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.87e-06	4.96e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.86e-06	4.94e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.84e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.84e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.84e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.82e-06	4.9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.77e-06	4.84e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.77e-06	4.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.71e-06	4.76e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.68e-06	4.72e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.66e-06	4.69e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.64e-06	4.67e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.62e-06	4.65e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.61e-06	4.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.58e-06	4.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.58e-06	4.59e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.56e-06	4.56e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.53e-06	4.52e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.5e-06	4.48e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.49e-06	4.48e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.47e-06	4.45e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.46e-06	4.43e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.44e-06	4.41e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.44e-06	4.4e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.44e-06	4.4e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.43e-06	4.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.42e-06	4.38e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.42e-06	4.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.41e-06	4.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.39e-06	4.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.32e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.28e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.15e-06	4.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.09e-06	3.96e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.01e-06	3.86e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.99e-06	3.83e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.98e-06	3.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.96e-06	3.8e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.96e-06	3.8e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.95e-06	3.79e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.95e-06	3.78e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.94e-06	3.77e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.93e-06	3.75e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.93e-06	3.75e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.91e-06	3.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.89e-06	3.71e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.82e-06	3.62e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	3.52e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.71e-06	3.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	3.46e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.68e-06	3.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	3.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.63e-06	3.37e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.59e-06	3.32e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.59e-06	3.32e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-06	3.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-06	3.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.56e-06	3.28e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-06	3.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	3.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.5e-06	3.21e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	3.11e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.38e-06	3.05e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.37e-06	3.04e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-06	3.01e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	2.96e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.29e-06	2.94e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	2.91e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	2.9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.23e-06	2.86e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	2.81e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	2.81e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	2.57e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	2.52e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	2.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	2.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	2.17e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	2.17e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.99e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.53e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	1.51e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.78e-07	9.98e-06	CbGpPWpGaD
